Clustering of polyclonal VanB-type vancomycin-resistant Enterococcus faecium in a low-endemic area was associated with CC17-genogroup strains harbouring transferable vanB2-Tn5382 and pRUM-like repA containing plasmids with axe-txe plasmid addiction systems

APMIS

Volumn 119, Issue 4-5, 2011, Pages 247-258

  Bjørkeng, Eva ^a   Rasmussen, Gunlög ^b   Sundsfjord, Arnfinn ^a,c   Sjöberg, Lennart ^b   Hegstad, Kristin ^a,c   Söderquist, Bo ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Axetxe; CC17; E. faecium; VRE

Indexed keywords

NUCLEASE; TEICOPLANIN; TRIMETHOPRIM; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENDEMIC SPECIES; GENE CLUSTER; GENE LOCATION; GENOTYPE; HOSPITAL PATIENT; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BASE SEQUENCE; CLUSTER ANALYSIS; CONJUGATION, GENETIC; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENDEMIC DISEASES; ENTEROCOCCUS FAECIUM; FEMALE; GENES, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PLASMIDS; SWEDEN; VANCOMYCIN RESISTANCE; VIRULENCE;

EID: 79954743999     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02724.x     Document Type: Article

References (75)

1. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997;18:622-7.
2. Neely AN, Maley MP. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 2000;38:724-6.
3. Noskin GA, Stosor V, Cooper I, Peterson LR. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995;16:577-81.
4. Patel R. Vancomycin-resistant enterococci in solid organ transplantation. Curr Opin Organ Transplant 1999;4:271-8.
5. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990;3:46-65.
6. Kearns AM, Freeman R, Lightfoot NF. Nosocomial enterococci: resistance to heat and sodium hypochlorite. J Hosp Infect 1995;30:193-9.
7. Freeman R, Kearns AM, Lightfoot NF. Heat resistance of nosocomial enterococci. Lancet 1994;344:64-5.
8. Bradley CR, Fraise AP. Heat and chemical resistance of enterococci. J Hosp Infect 1996;34:191-6.
9. Chavers LS, Moser SA, Benjamin WH, Banks SE, Steinhauer JR, Smith AM, et al. Vancomycin-resistant enterococci: 15years and counting. J Hosp Infect 2003;53:159-71.
10. Iwen PC, Kelly DM, Linder J, Hinrichs SH, Dominguez EA, Rupp ME, et al. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother 1997;41:494-5.
11. Willems RJ, Top J, van SM, Robinson DA, Coque TM, Baquero F, et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005;11:821-8.
12. Arias CA, Contreras GA, Murray BE. Management of multi-drug resistant enterococcal infections. Clin Microbiol Infect 2010;16:555-62.
13. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
14. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988;1:57-8.
15. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008;13:1-11.
16. Xu X, Lin D, Guo Y, Wu S, Ye X, Zhu D, et al. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 2010;54:4643-7.
17. Leclercq R, Lebreton F, Cattoir V. Mechanisms of resistance to vancomycin. ESCMID Conference on Enterococci: from Animals to Man, Barcelona, Spain 2009: 11.
18. Werner G, Strommenger B, Witte W. Acquired vancomycin resistance in clinically relevant pathogens. Future Microbiol 2008;3:547-62.
19. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006;42(Suppl 1):S25-34.
20. Quintiliani J, Courvalin P. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. FEMS Microbiol Lett 1994;119:359-63.
21. Rice LB, Carias LL, Donskey CL, Rudin SD. Transferable, plasmid-mediated vanB-type glycopeptide resistance in Enterococcus faecium. Antimicrob Agents Chemother 1998;42:963-4.
22. Carias LL, Rudin SD, Donskey CJ, Rice LB. Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 1998;180:4426-34.
23. Garnier F, Taourit S, Glaser P, Courvalin P, Galimand M. Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp. Microbiology 2000;146:1481-9.
24. Dahl KH, Rokenes TP, Lundblad EW, Sundsfjord A. Nonconjugative transposition of the vanB-containing Tn5382-like element in Enterococcus faecium. Antimicrob Agents Chemother 2003;47:786-9.
25. Zheng B, Tomita H, Inoue T, Ike Y. Isolation of vanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, encoding vanB-type vancomycin vesistance and a Bac41-type bacteriocin, and pMG2201, encoding erythromycin eesistance and cytolysin (Hly/Bac). Antimicrob Agents Chemother 2009;53:735-47.
26. Dahl KH, Lundblad EW, Rokenes TP, Olsvik O, Sundsfjord A. Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-resistant enterococci and characterization of two novel insertion sequences. Microbiology 2000;146:1469-79.
27. Umeda A, Garnier F, Courvalin P, Galimand M. Association between the vanB2 glycopeptide resistance operon and Tn1549 in enterococci from France. J Antimicrob Chemother 2002;50:253-6.
28. Willems RJ, van Schaik W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol 2009;4:1125-35.
29. Torell E, Fredlund H, T̈örnquist E, Myhre EB, Sjöberg L, Sundsfjord A. Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 1997;29:259-63.
30. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR [published erratum appears in J Clin Microbiol 1995;33:1434]. J Clin Microbiol 1995;33:24-7.
31. Saeedi B, Hallgren A, Jonasson J, Nilsson LE, Hanberger H, Isaksson B. Modified pulsed-field gel electrophoresis protocol for typing of enterococci. APMIS 2002;110:869-74.
32. Carrico JA, Pinto FR, Simas C, Nunes S, Sousa NG, Frazao N, et al. Assessment of band-based similarity coefficients for automatic type and subtype classification of microbial isolates analyzed by pulsed-field gel electrophoresis. J Clin Microbiol 2005;43:5483-90.
33. Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002;40:1963-71.
34. Leavis HL, Willems RJ, Top J, Spalburg E, Mascini EM, Fluit AC, et al. Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg Infect Dis 2003;9:1108-15.
35. Rice LB, Carias L, Rudin S, Vael C, Goossens H, Konstabel C, et al. A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 2003;187:508-12.
36. Nallapareddy SR, Weinstock GM, Murray BE. Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol 2003;47:1733-47.
37. Hendrickx APA, van Wamel WJB, Posthuma G, Bonten MJM, Willems RJL. Five genes encoding surface-exposed LPXTG proteins are enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates. J Bacteriol 2007;189:8321-32.
38. Palladino S, Kay ID, Flexman JP, Boehm I, Costa AM, Lambert EJ, et al. Rapid detection of vanA and vanB genes directly from clinical xpecimens and enrichment broths by real-time multiplex PCR assay. J Clin Microbiol 2003;41:2483-6.
39. Dahl KH, Simonsen GS, Olsvik O, Sundsfjord A. Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci. Antimicrob Agents Chemother 1999;43:1105-10.
40. Garcia-Migura L, Liebana E, Jensen L. Transposon characterization of vancomycin-resistant Enterococcus faecium (VREF) and dissemination of resistance associated with transferable plasmids. J Antimicrob Chemother 2007;60:263-8.
41. Grady R, Hayes F. Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol Microbiol 2003;47:1419-32.
42. Rosvoll TC, Pedersen T, Sletvold H, Johnsen PJ, Sollid JE, Simonsen GS, et al. PCR-based plasmid typing in Enterococcus faecium strains reveals widely distributed pRE25-, pRUM-, pI. FEMS Immunol Med Microbiol 2009;58:254-68.
43. Harthug S, Digranes A, Hope O, Kristiansen BE, Allum AG, Langeland N. Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium. Clin Microbiol Infect 2000;6:19-28.
44. Arduino RC, Murray BE, Rakita RM. Roles of antibodies and complement in phagocytic killing of enterococci. Infect Immun 1994;62:987-93.
45. Johnsen PJ, Østerhus JI, Sletvold H, Sørum M, Kruse H, Nielsen K, et al. Persistence of animal and human glycopeptide-resistant enterococci on two norwegian poultry farms formerly exposed to avoparcin is associated with a widespread plasmid-mediated vanA element within a polyclonal Enterococcus faecium population. Appl Environ Microbiol 2005;71:159-68.
46. Paulsen IT, Banerjei L, Myers GSA, Nelson KE, Seshadri R, Read TD, et al. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 2003;299:2071-4.
47. Poyart C, Trieu-Cuot P. Heterogeneric conjugal transfer of the pheromone-responsive plasmid pIP964 (IncHlyI) of Enterococcus faecalis in the apparent absence of pheromone induction. FEMS Microbiol Lett 1994;122:173-9.
48. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991;173:697-703.
49. Leavis HL, Willems RJL, Top J, Bonten MJM. High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. J Clin Microbiol 2006;44:1059-64.
50. Hanrahan J, Hoyen C, Rice LB. Geographic distribution of a large mobile element that transfers ampicillin and vancomycin resistance between Enterococcus faecium strains. Antimicrob Agents Chemother 2000;44:1349-51.
51. Jensen LB, Garcia-Migura L, Valenzuela AJ, Lohr M, Hasman H, Aarestrup FM. A classification system for plasmids from enterococci and other Gram-positive bacteria. J Microbiol Methods 2010;80:25-43.
52. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000;13:686-707.
53. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003;51(Suppl 3):iii13-21.
54. Granlund M, Carlsson C, Edebro H, Emanuelsson K, Lundholm R. Nosocomial outbreak of vanB2 vancomycin-resistant Enterococcus faecium in Sweden. J Hosp Infect 2006;62:254-6.
55. Ruiz-Garbajosa P, Top J, Coque TM, Canton R, Bonten M, Baquero F, et al. Increased mutation frequency among Enterococcus faecium belonging to clonal complex 17. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain 2008: 2043.
56. Carlos AR, Semedo-Lemsaddek T, Barreto-Crespo MT, Tenreiro R. Transcriptional analysis of virulence-related genes in enterococci from distinct origins. J Appl Microbiol 2010;108:1563-75.
57. Rice LB, Laktikova V, Carias LL, Rudin S, Hutton R, Marshall SH. Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model. J Infect Dis 2009;199:342-9.
58. Klare I, Konstabel C, Mueller-Bertling S, Werner G, Strommenger B, Kettlitz C, et al. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis 2005;24:815-25.
59. Heikens E, Bonten MJ, Willems RJ. Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 2007;189:8233-40.
60. Willems RJL, Homan W, Top J, van Santen-Verheuvel M, Tribe D, Manzioros X, et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycinresistant Enterococcus faecium spreading in hospitals. Lancet 2001;357:853-5.
61. Billstrom H, Top J, Edlund C, Lund B. Frequent occurrence of multidrug-resistant CC17 Enterococcus faecium among clinical isolates in Sweden. J Appl Microbiol 2009;108:1810-6.
62. Dahl KH, Sundsfjord A. Transferable vanB2 Tn5382-containing elements in fecal streptococcal strains from veal calves. Antimicrob Agents Chemother 2003;47:2579-83.
63. Sletvold H, Johnsen PJ, Simonsen GS, Aasnaes B, Sundsfjord A, Nielsen KM. Comparative DNA analysis of two vanA plasmids from Enterococcus faecium strains isolated from poultry and a poultry farmer in Norway. Antimicrob Agents Chemother 2007;51:736-9.
64. Sørum M, Johnsen PJ, Aasnes B, Rosvoll T, Kruse H, Sundsfjord A, et al. Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in norwegian poultry and poultry farmers 3 to 8years after the ban on avoparcin. Appl Environ Microbiol 2006;72:516-21.
65. Dahl KH, Mater DD, Flores MJ, Johnsen PJ, Midtvedt T, Corthier G, et al. Transfer of plasmid and chromosomal glycopeptide resistance determinants occurs more readily in the digestive tract of mice than in vitro and exconjugants can persist stably in vivo in the absence of glycopeptide selection. J Antimicrob Chemother 2007;59:478-86.
66. Domingo MC, Huletsky A, Giroux R, Boissinot K, Picard FJ, Lebel P, et al. High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob Agents Chemother 2005;49:4784-6.
67. Demertzi E, Palepou MF, Kaufmann ME, Avlamis A, Woodford N. Characterisation of vanA and vanB elements from glycopeptide-resistant Enterococcus faecium from Greece. J Med Microbiol 2001;50:682-7.
68. Lopez M, Hormazabal JC, Maldonado A, Saavedra G, Baquero F, Silva J, et al. Clonal dissemination of Enterococcus faecalis ST201 and Enterococcus faecium CC17-ST64 containing Tn5382-vanB2 among 16 hospitals in Chile. Clin Microbiol Infect 2009;15:586-8.
69. Lorenzo-Diaz F, Delgado T, Reyes-Darias JA, Flores C, Mendez-Alvarez S, Villar J, et al. Characterization of the first VanB vancomycin-resistant Enterococcus faecium isolated in a Spanish hospital. Curr Microbiol 2004;48:199-203.
70. Lu JJ, Chang TY, Perng CL, Lee SY. The vanB2 gene cluster of the majority of vancomycin-resistant Enterococcus faecium isolates from Taiwan is associated with the pbp5 gene and is carried by Tn5382 containing a novel insertion sequence. Antimicrob Agents Chemother 2005;49:3937-9.
71. McGregor KF, Nolan C, Young HK, Palepou MF, Tysall L, Woodford N. Prevalence of the vanB2 gene cluster in vanB glycopeptide-resistant enterococci in the United Kingdom and the Republic of Ireland and its association with a Tn5382-like element. Antimicrob Agents Chemother 2001;45:367-8.
72. Seville LA, Patterson AJ, Scott KP, Mullany P, Quail MA, Parkhill J, et al. Distribution of tetracycline and erythromycin resistance genes among human oral and fecal metagenomic DNA. Microb Drug Resist 2009;15:159-66.
73. Ballard SA, Pertile KK, Lim M, Johnson PDR, Grayson ML. Molecular characterization of vanB elements in naturally occurring gut Anaerobes. Antimicrob Agents Chemother 2005;49:1688-94.
74. Domingo MC, Huletsky A, Bernal A, Giroux R, Boudreau DK, Picard FJ, et al. Characterization of a Tn5382-like transposon containing the vanB2 gene cluster in a Clostridium strain isolated from human faeces. J Antimicrob Chemother 2005;55:466-74.
75. Leavis HL, Bonten MJ, Willems RJ. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006;9:454-60.